• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Suck-U-Surge Revisited

  • Tue, 5/24/11 - 9:12am
  • 1865 reads
  • 1 comments

Clinical History

A 78-year-old male with no known coronary disease presented with worsening congestive heart failure symptoms. He previously had bypass surgery. His presentation revealed his saphenous vein graft to the circumflex was widely patent a year before. He presented with angina and inferior lateral ischemia. A diagnostic study was performed. His right coronary artery was stented at 2 focal areas, and he was brought back for intervention 3 days later. We did both the initial procedure as well as the follow-up procedure via the right radial artery.

Instead of just performing balloon angioplasty, we performed suction thrombectomy with an Export® catheter (Medtronic CardioVascular, Minneapolis, Minnesota) removing massive amounts of red and white thrombus. Following the removal, TIMI flow was 3. We attempted to place an Abbott embolic protection device (Abbott Vascular, Abbott Park, Illinois); however, it was too stiff to be able to be placed in the bypass graft. Balloon angioplasty using the suck-u-surge technique was then performed.1,2

Following this, normal TIMI 3 flow was noted. The patient was discharged the following day. Thrombectomy with the suck-u-surge technique is effective in saphenous vein graft stenosis when an embolic protection device cannot be passed.

Figure 1. The angiogram showing the total occlusion of the saphenous vein graft

­

 

 

Figure 2. The saphenous vein graft to the circumflex was crossed with a Transit™ catheter (Cordis, Bridgewater, New Jersey) and Whisper® wire (Abbott Vascular, Abbott Park, Illinois)

 

 

Figure 3a. The technique performing with negative suction and a guiding catheter at the time of balloon inflation

 

 

 

Figure 3b. A stent is deployed with negative suction

 

 

 

 Figure 4. Angiogram confirms placement in bypass graft

 

 

Figure 5. A 3.5 x 30 mm Endeavor® stent (Medtronic, Inc., Sunnyvale, California) was placed using the suck-u-surge technique

 

 

Figure 6. Final result

 

 

 

 References

  1. Morales PA, Heuser RR. Guiding catheter aspiration to prevent embolic events during saphenous vein graft intervention. J Interv Cardiol 2002;15:491–498.
  2. Heuser RR. Letter to the Editor. Contemporary Use of Embolic Protection Devices in Saphenous Vein Graft Interventions: Insights from the Stent of Saphenous Vein Grafts Trial. Catheter Cardiovasc Interv 2011;77:594.

 ________________________________

Richard R. Heuser, MD, FACC, FACP, FESC, FSCAI, is an internationally-recognized cardiologist, inventor, educator and author. A diplomate of the American Board of Cardiovascular Diseases and American Board of Interventional Cardiovascular Diseases, Dr. Heuser is one of the early pioneers of angioplasty and is considered one of America’s top cardiologists. Dr. Heuser is currently in practice at the Phoenix Heart Center/Physicians Group of Arizona. He is Chief of Cardiology and Chief of Cardiac Catheterization Laboratory at St. Luke’s Hospital and Medical Center, Phoenix, Arizona, and Clinical Professor of Medicine at the University of Arizona College of Medicine, as well as Director of the Interventional Fellowship Program at the University of Arizona College of Medicine, Phoenix Campus.

With 13 patents granted for different catheters, stents and other medical devices, Dr. Heuser has served as principal investigator to research the safety and/or effectiveness of more than 100 medical devices and 70 pharmaceutical products, and has participated in more than 150 research studies. He has authored over 400 articles, textbooks and medical manuscripts, and is frequently invited to international medical conferences to present the findings of research developed in Phoenix.

Dr. Heuser received his medical degree from the University of Wisconsin School of Medicine in Madison, Wisconsin, and completed his medicine internship and residency, as well as his cardiology fellowship, at The Johns Hopkins Hospital in Baltimore, Maryland.

image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


zaklady bukmacherskiesays: November 27.2011 at 17:24 pm

I saw many sites but yours is very interesting, you got talent in writing articles, blog bookmarked! Waiting for more info!

Reply to this comment »

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Tara Fields, Classified Sales Manager
    (800) 237-7285, ext. 259

vdm Blogs

EVAR found superior to open AAA repair for long-term survival in Medicare patients: Another nail in open surgery’s coffin?

Frank J Criado MD FACS FSVM

Aneurysms and Cancer: Which comes first in the endovascular era?

Ross Milner MD FACS

What is the best therapy when we compare current data for revascularization of the SFA?

Lawrence A. Garcia MD

When a Patient Presents with an Ulcer, Take a Careful History

Richard R. Heuser MD FACC FACP FESC FSCAI

Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies?

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
    Thu, 05/17/12 - 10:22am
  • Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
    Wed, 05/16/12 - 9:26am
  • Hospital Mortality Rates for Cardiovascular Revascularization Patients Varies Significantly by State
    Tue, 05/15/12 - 9:31am
  • Boston Scientific Announces CE Mark and European Launch of Innova Self-expanding Bare-metal Stent System
    Mon, 05/14/12 - 12:07pm
more »

Clinical Events Calendar

  • EuroPCR 2012
    Tue, 05/15/2012 - Fri, 05/18/2012
    Paris, France
  • International Vein Congress (IVC) 2012
    Thu, 05/31/2012 - Sun, 06/03/2012
    Miami Beach, FL, United States
  • New Cardiovascular Horizons (NCVH)
    Wed, 06/06/2012 - Sat, 06/09/2012
    New Orleans, LA, United States
more »

Poll

The current focus to decrease the profile size of aortic stent-grafts: :
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications